scispace - formally typeset
J

JingQi Huang

Researcher at Merck & Co.

Publications -  11
Citations -  906

JingQi Huang is an academic researcher from Merck & Co.. The author has contributed to research in topics: Computer science & Caspase. The author has an hindex of 7, co-authored 7 publications receiving 879 citations.

Papers
More filters
Journal ArticleDOI

Differential Efficacy of Caspase Inhibitors on Apoptosis Markers during Sepsis in Rats and Implication for Fractional Inhibition Requirements for Therapeutics

TL;DR: Findings suggest that putative caspase-independent apoptosis may be overestimated in some systems since blockade of spectrin proteolysis and other cell death markers does not accurately reflect the high degrees of casp enzyme-3 inhibition needed to prevent DNA fragmentation.
Journal ArticleDOI

Disruption of largest subunit RNA polymerase II genes in Trypanosoma brucei.

TL;DR: It is concluded that the alpha-amanitin-resistant transcription of protein coding genes in T. brucei is not mediated by a diverged form of the largest subunit of pol II and that the presence of both the pol IIA and pol IIB genes is not essential for trypanosome viability.
Journal ArticleDOI

A Caspase Active Site Probe Reveals High Fractional Inhibition Needed to Block DNA Fragmentation

TL;DR: The use of a novel radiolabeled caspase inhibitor, [125I]M808, and an active site occupancy assay, which measure the fractional inhibition required to block apoptosis-induced DNA fragmentation suggest that a high and persistent fractional inhibited will be required for successful caspases inhibition-based therapies.
Patent

Antibodies that recognize app cleaved by caspases and methods of use

TL;DR: In this paper, the roles of apoptotic proteases and caspases in cleavage of amyloid-β precursor protein (APP) and biogenesis of AMyloidogenic Aβ peptide species are described.